Delivering Value To Those We Serve

Overview

Recent News

Date Title and Summary
Toggle Summary Activbiotics and De[pomed Announce Aagreement to Develop New Product for the Treatment of Acute and Chronic Gastrointestinal Diseases
Cambridge, MA and Menlo Park, CA, October 15, 2002. -- ActivBiotics, Inc. and DepoMed, Inc. (AMEX:DMI) today announced a memorandum of understanding under which DepoMed will develop a controlled-release oral tablet which delivers ActivBiotics' broad spectrum lead compound, rifalazil, to the
Toggle Summary AMEX Approves Depomed's Continued Listings Plan
MENLO PARK, Calif. – September 20, 2002 – DepoMed today announced that on September 17, 2002, the Company received notice from the staff of the American Stock Exchange that the AMEX had accepted the Company's plan to regain compliance with AMEX listing standards and had granted the Company an
Toggle Summary Appeals Court Upholds Depomed Patents Asserted against Purdue Pharma
NEWARK, Calif. , March 24, 2016 (GLOBE NEWSWIRE) -- Depomed (NASDAQ:DEPO) announced today that the U.S. Court of Appeals for the Federal Circuit has affirmed the decisions of the Patent Trial and Appeal Board of the United States Patent and Trademark Office (PTAB) confirming the patentability of
Upcoming Events
Date Event Details Remind Me
May 11, 2021 at 1:00 PM CDT
Presentations

Recent SEC Filings

Filing date Description Form Filing Group View

Official notification to shareholders of matters to be brought to a vote ("Proxy")

DEF 14A
Proxy Filings
View HTML

A preliminary proxy statement providing notification matters to be brought to a vote

PRE 14A
Proxy Filings
View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

Initial filing by director officer or owner of more than ten percent.

3
3,4,5
View HTML

Initial filing by director officer or owner of more than ten percent.

3
3,4,5
View HTML

IR Contact

Transfer Agent

Continental Stock Transfer & Trust Company
17 Battery Place, 8th Floor
New York, NY 10004
Phone: 800.509.5586
http://www.continentalstock.com
 

Independent Registered Public Accounting Firm

Grant Thornton LLP
Chicago, IL
 

Investor Relations Contact

Max Nemmers
Head, Investor Relations and Administration
investor@assertiotx.com